Tuesday, November 7, 2006 7:45:00 AM PDT | VentureDeal Staff
ROCHESTER, NY -- iCardiac Technologies, Inc., announced that it has closed its Series A round by getting an additional $2 million investment. Total investment for the round was $4 million. iCardiac was formed earlier this year to commercialize technologies licensed from the University of Rochester that enable the identification of biomarkers in drugs that would increase cardiac risks. Investors Advantage Capital Partners and Stonehenge Capital Company led the round and invested in conjunction with New York's Certified Capital Companies program.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
